Interestingly, the fusion genes identified by analyzing breast cancer genome rearrangements indicated that ErbB2 might serve as an adaptor for DEPTOR in regulating the mTOR pathway 25, thus adding another layer of complexity in the cross-talk between DEPTOR and ErbB2 in breast tumorigenesis. Here, ERBB2 is linked to breast carcinoma.